Hospitalization after antibiotic initiation found to be higher for people with Alzheimer’s disease

NewsGuard 100/100 Score

Persons with Alzheimer's disease (AD) are more often hospitalized after antibiotic initiation than people without AD, a new study from the University of Eastern Finland shows. The risk of hospitalization was 40 percent higher for persons with Alzheimer's disease. The findings were published in Journal of Alzheimer's Disease.

Out of individual antibiotics, persons with Alzheimer's disease were more often hospitalized than people without AD after the initiation of cephalexine, pivmecillinam, amoxicillin and doxycycline. Hospitalization was associated with pre-existing illnesses, such as epilepsy or cancer, and certain medications, such as antipsychotic and benzodiazepine use.

This study used data from a Finnish register-based cohort, which includes all persons diagnosed with Alzheimer's disease in Finland during 2005-2011. The researchers analyzed 34,785 persons who used antibiotics in an outpatient setting after their Alzheimer's disease diagnosis, and their comparison persons matched according to age, sex and region of residence.

Previous studies have shown that infections are a significant cause of hospitalization in persons with dementia. This study is the first to document hospitalization after antibiotic initiation. These results confirm the role of infections as a cause of hospitalization in persons with Alzheimer's disease.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
International research collaboration leads to breakthrough in antibiotic resistance testing using DNA sequencing